UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Leukemia, 2015-08, Vol.29 (8), p.1721-1729

2015

Volltextzugriff (PDF)

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

Leukemia, 2014-09, Vol.28 (9), p.1902-1908

2014

Volltextzugriff (PDF)

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Haematologica (Roma), 2011-01, Vol.96 (1), p.87-95

2011

Volltextzugriff (PDF)

Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance

Leukemia, 2014-01, Vol.28 (1), p.174-178

2014

Volltextzugriff (PDF)

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

Leukemia, 2016-06, Vol.30 (6), p.1255-1262

2016

Volltextzugriff (PDF)

Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents

Annals of oncology, 2014-01, Vol.25 (1), p.189-195

2014

Volltextzugriff (PDF)

Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (9), p.3103-3111

2004

Volltextzugriff (PDF)

Centrosome replication, genomic instability and cancer

Leukemia, 2002-05, Vol.16 (5), p.767-775

2002

Volltextzugriff (PDF)

Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma

International journal of hematology, 2011-06, Vol.93 (6), p.791-794

2011

Volltextzugriff (PDF)

Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure

Bone marrow transplantation (Basingstoke), 2014-11, Vol.49 (11), p.1371-1375

2014

Volltextzugriff (PDF)

Strategien beim rezidivierten/refraktären multiplen Myelom

Der Onkologe, 2014-03, Vol.20 (3), p.250-256

2014

Volltextzugriff (PDF)

Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation

International journal of hematology, 2013-06, Vol.97 (6), p.765-772

2013

Volltextzugriff (PDF)

Dose-dependent Effect of Thalidomide on Overall Survival in Relapsed Multiple Myeloma

Clinical cancer research, 2002-11, Vol.8 (11), p.3377-3382

2002

Volltextzugriff (PDF)

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy

Blood, 2001-12, Vol.98 (13), p.3846-3848

2001

Volltextzugriff (PDF)

High Plasma Basic Fibroblast Growth Factor Concentration Is Associated with Response to Thalidomide in Progressive Multiple Myeloma

Clinical cancer research, 2001-09, Vol.7 (9), p.2675-2681

2001

Volltextzugriff (PDF)

Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q

Oncogene, 2007-07, Vol.26 (34), p.5010-5016

2007

Volltextzugriff (PDF)

Molekulare Pathogenese und Biologie des CUP-Syndroms

Der Onkologe, 2008-09, Vol.14 (9), p.860-869

2008

Volltextzugriff (PDF)

Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma

Leukemia, 2003-11, Vol.17 (11), p.2207-2213

2003

Volltextzugriff (PDF)

Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma

Haematologica (Roma), 2012-11, Vol.97 (11), p.1757-1760

2012

Volltextzugriff (PDF)

Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma

American journal of hematology, 2012-10, Vol.87 (10), p.E68-E71

2012

Volltextzugriff (PDF)

1230P Elderly patients treated with afatinib in clinical practice: Final results of the GIDEON study in EGFR mutated NSCLC in Germany

Annals of oncology, 2021-09, Vol.32, p.S974-S974

2021

Volltextzugriff (PDF)

Dynamische MRT des Knochenmarks zum Monitoring des Multiplen Myeloms unter Thalidomid-Monotherapie oder Kombination mit CED-Chemotherapie

RöFo : Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebende Verfahren, 2004-09, Vol.176 (9), p.1285-1295

2004

Volltextzugriff (PDF)

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation

Haematologica (Roma), 2010-07, Vol.95 (7), p.1150-1157

2010

Volltextzugriff (PDF)

1 – 25 von 252

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(230)
Mit Volltextzugriff
(210)

Publikationsform

Sprache

Englisch
(237)
Deutsch
(17)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Report from the European Myeloma Network on interphase FISH in multiple myeloma and related disorders

Phase III trial of bortezomib, cyclophosphamide and dexamethasone (VCD) versus bortezomib, doxorubicin and dexamethasone (PAd) in newly diagnosed myeloma

Predictive value of longitudinal whole-body magnetic resonance imaging in patients with smoldering multiple myeloma

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment: long-term observation in CML Study IV

Autologous stem cell transplantation for elderly patients with newly diagnosed multiple myeloma in the era of novel agents

Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival

Centrosome replication, genomic instability and cancer

Inflammatory autoimmune neuropathy, presumably induced by bortezomib, in a patient suffering from multiple myeloma

Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure

Strategien beim rezidivierten/refraktären multiplen Myelom

Bisphosphonate treatment and renal function in 201 myeloma patients undergoing stem cell transplantation

Dose-dependent Effect of Thalidomide on Overall Survival in Relapsed Multiple Myeloma

Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy

High Plasma Basic Fibroblast Growth Factor Concentration Is Associated with Response to Thalidomide in Progressive Multiple Myeloma

Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q

Molekulare Pathogenese und Biologie des CUP-Syndroms

Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma

Changes in magnetic resonance imaging before and after autologous stem cell transplantation correlate with response and survival in multiple myeloma

Final results of a randomized trial comparing 1, 3, or 6 infusions of Rituximab plus 6 cycles CHOP provide valuable preliminary data towards a more cost-effective and safer treatment of advanced follicular lymphoma

1230P Elderly patients treated with afatinib in clinical practice: Final results of the GIDEON study in EGFR mutated NSCLC in Germany

High-risk additional chromosomal abnormalities at low blast counts herald death by CML

Dynamische MRT des Knochenmarks zum Monitoring des Multiplen Myeloms unter Thalidomid-Monotherapie oder Kombination mit CED-Chemotherapie

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation

Suchergebnisse filtern